Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 587

1.

An update on the unparalleled impact of FDG-PET imaging on the day-to-day practice of medicine with emphasis on management of infectious/inflammatory disorders.

Alavi A, Hess S, Werner TJ, Høilund-Carlsen PF.

Eur J Nucl Med Mol Imaging. 2019 Sep 4. doi: 10.1007/s00259-019-04490-6. [Epub ahead of print] No abstract available.

PMID:
31482427
2.

Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial.

Mirza MR, Åvall Lundqvist E, Birrer MJ, dePont Christensen R, Nyvang GB, Malander S, Anttila M, Werner TL, Lund B, Lindahl G, Hietanen S, Peen U, Dimoula M, Roed H, Ør Knudsen A, Staff S, Krog Vistisen A, Bjørge L, Mäenpää JU; AVANOVA investigators.

Lancet Oncol. 2019 Aug 29. pii: S1470-2045(19)30515-7. doi: 10.1016/S1470-2045(19)30515-7. [Epub ahead of print]

PMID:
31474354
3.

The Mitsunobu reaction, reimagined.

Longwitz L, Werner T.

Science. 2019 Aug 30;365(6456):866-867. doi: 10.1126/science.aay6635. No abstract available.

PMID:
31467210
4.

Effects of a 12-Week Resistance Training Program on Arterial Stiffness: A Randomized Controlled Trial.

Werner TJ, Pellinger TK, Rosette VD, Ortlip AT.

J Strength Cond Res. 2019 Aug 15. doi: 10.1519/JSC.0000000000003331. [Epub ahead of print]

PMID:
31425456
5.

Blockade of miR-140-3p prevents functional deterioration in afterload-enhanced engineered heart tissue.

Werner TR, Kunze AC, Stenzig J, Eschenhagen T, Hirt MN.

Sci Rep. 2019 Aug 7;9(1):11494. doi: 10.1038/s41598-019-46818-0.

6.

NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019.

Armstrong DK, Alvarez RD, Bakkum-Gamez JN, Barroilhet L, Behbakht K, Berchuck A, Berek JS, Chen LM, Cristea M, DeRosa M, ElNaggar AC, Gershenson DM, Gray HJ, Hakam A, Jain A, Johnston C, Leath CA III, Liu J, Mahdi H, Matei D, McHale M, McLean K, O'Malley DM, Penson RT, Percac-Lima S, Ratner E, Remmenga SW, Sabbatini P, Werner TL, Zsiros E, Burns JL, Engh AM.

J Natl Compr Canc Netw. 2019 Aug 1;17(8):896-909. doi: 10.6004/jnccn.2019.0039.

PMID:
31390583
7.

Author Correction: Differentiation of cardiomyocytes and generation of human engineered heart tissue.

Breckwoldt K, Brenière-Letuffe D, Mannhardt I, Schulze T, Ulmer B, Werner T, Benzin A, Klampe B, Reinsch MC, Laufer S, Shibamiya A, Prondzynski M, Mearini G, Schade D, Fuchs S, Neuber C, Krämer E, Saleem U, Schulze ML, Rodriguez ML, Eschenhagen T, Hansen A.

Nat Protoc. 2019 Sep;14(9):2748. doi: 10.1038/s41596-019-0228-5.

PMID:
31384055
8.

Sacroiliac Joint Asymmetry Regarding Inflammation and Bone Turnover: Assessment by FDG and NaF PET/CT.

Al-Zaghal A, Yellanki DP, Kothekar E, Werner TJ, Høilund-Carlsen PF, Alavi A.

Asia Ocean J Nucl Med Biol. 2019 Spring;7(2):108-114. doi: 10.22038/AOJNMB.2019.40820.1275.

9.

A Phase IV, Randomized, Double-Blind, Placebo-Controlled Crossover Study of the Effects of Ustekinumab on Vascular Inflammation in Psoriasis (the VIP-U trial).

Gelfand JM, Shin DB, Alavi A, Torigian DA, Werner T, Papadopoulos M, Takeshita J, Noe MH, Dey AK, Playford MP, Mehta NN.

J Invest Dermatol. 2019 Jul 18. pii: S0022-202X(19)32537-0. doi: 10.1016/j.jid.2019.07.679. [Epub ahead of print]

PMID:
31326395
10.

18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.

Khosravi M, Peter J, Wintering NA, Serruya M, Shamchi SP, Werner TJ, Alavi A, Newberg AB.

J Alzheimers Dis. 2019;70(4):1197-1207. doi: 10.3233/JAD-190220.

PMID:
31322568
11.

Prognostic factors for rural endometrial cancer patients in a population-based cohort.

Blackburn BE, Soisson S, Rowe K, Snyder J, Fraser A, Deshmukh V, Newman M, Smith K, Herget K, Kirchhoff AC, Kepka D, Werner TL, Gaffney D, Mooney K, Hashibe M.

BMC Public Health. 2019 Jul 10;19(1):921. doi: 10.1186/s12889-019-7262-7.

12.

18F-NaF Uptake in Ocular Prosthesis (Implant).

Kothekar E, Seraj SM, Kaghazchi F, Werner TJ, Alavi A.

Clin Nucl Med. 2019 Jul 5. doi: 10.1097/RLU.0000000000002700. [Epub ahead of print]

PMID:
31283607
13.

A FRET-Based Near-Infrared Fluorescent Probe for Ratiometric Detection of Cysteine in Mitochondria.

Xia S, Zhang Y, Fang M, Mikesell L, Steenwinkel TE, Wan S, Phillips T, Luck RL, Werner T, Liu H.

Chembiochem. 2019 Aug 1;20(15):1986-1994. doi: 10.1002/cbic.201900071. Epub 2019 Jun 14.

PMID:
31197917
14.

Lymphovascular Invasion in Endometrial Cancer: Prognostic Value and Implications on Adjuvant Radiation Therapy Use.

Boothe D, Wolfson A, Christensen M, Francis S, Werner TL, Gaffney DK.

Am J Clin Oncol. 2019 Jul;42(7):549-554. doi: 10.1097/COC.0000000000000559.

PMID:
31169554
15.

Detection of coronary inflammation.

Alavi A, Werner TJ, Al-Zaghal A.

Lancet. 2019 Jun 1;393(10187):2198. doi: 10.1016/S0140-6736(19)30224-7. No abstract available.

PMID:
31162078
16.

Organocatalytic Chlorination of Alcohols by P(III)/P(V) Redox Cycling.

Longwitz L, Jopp S, Werner T.

J Org Chem. 2019 Jun 21;84(12):7863-7870. doi: 10.1021/acs.joc.9b00741. Epub 2019 Jun 11.

PMID:
31135155
17.

18F-NaF Uptake in Calcified Uterine Leiomyoma.

Kothekar E, Raynor WY, Werner TJ, Alavi A, Baker JF.

Clin Nucl Med. 2019 May 3. doi: 10.1097/RLU.0000000000002628. [Epub ahead of print]

PMID:
31107758
18.

Quantification of global lung inflammation using volumetric 18F-FDG PET/CT parameters in locally advanced non-small-cell lung cancer patients treated with concurrent chemoradiotherapy: a comparison of photon and proton radiation therapy.

Rice SR, Saboury B, Houshmand S, Salavati A, Kalbasi A, Goodman CR, Werner TJ, Vujaskovic Z, Simone CB 2nd, Alavi A.

Nucl Med Commun. 2019 Jun;40(6):618-625. doi: 10.1097/MNM.0000000000000997.

PMID:
31095527
19.

Evolving Roles of Fluorodeoxyglucose and Sodium Fluoride in Assessment of Multiple Myeloma Patients: Introducing a Novel Method of PET Quantification to Overcome Shortcomings of the Existing Approaches.

Zadeh MZ, Raynor WY, Seraj SM, Ayubcha C, Kothekar E, Werner T, Alavi A.

PET Clin. 2019 Jul;14(3):341-352. doi: 10.1016/j.cpet.2019.03.004. Epub 2019 Apr 10. Review.

PMID:
31084774
20.

Recurrent early stage endometrial cancer: Patterns of recurrence and results of salvage therapy.

Francis SR, Ager BJ, Do OA, Huang YJ, Soisson AP, Dodson MK, Werner TL, Sause WT, Grant JD, Gaffney DK.

Gynecol Oncol. 2019 Jul;154(1):38-44. doi: 10.1016/j.ygyno.2019.04.676. Epub 2019 Apr 24.

PMID:
31029507
21.

Do vaginal recurrence rates differ among adjuvant vaginal brachytherapy regimens in early-stage endometrial cancer?

Ager BJ, Francis SR, Do OA, Huang YJ, Soisson AP, Dodson MK, Werner TL, Sause WT, Grant JD, Gaffney DK.

Brachytherapy. 2019 Jul - Aug;18(4):453-461. doi: 10.1016/j.brachy.2019.03.001. Epub 2019 Apr 17.

PMID:
31005603
22.

Processing of prompt gamma-ray timing data for proton range measurements at a clinical beam delivery.

Werner T, Berthold J, Hueso-González F, Koegler T, Petzoldt J, Roemer K, Richter C, Rinscheid A, Straessner A, Enghardt W, Pausch G.

Phys Med Biol. 2019 May 21;64(10):105023. doi: 10.1088/1361-6560/ab176d.

PMID:
30965311
23.

Analysis of fibrosis in control or pressure overloaded rat hearts after mechanical unloading by heterotopic heart transplantation.

Schaefer A, Schneeberger Y, Schulz S, Krasemann S, Werner T, Piasecki A, Höppner G, Müller C, Morhenn K, Lorenz K, Wieczorek D, Schwoerer AP, Eschenhagen T, Ehmke H, Reichenspurner H, Stenzig J, Cuello F.

Sci Rep. 2019 Apr 5;9(1):5710. doi: 10.1038/s41598-019-42263-1.

24.

Life Cycle Assessment for the Organocatalytic Synthesis of Glycerol Carbonate Methacrylate.

Büttner H, Kohrt C, Wulf C, Schäffner B, Groenke K, Hu Y, Kruse D, Werner T.

ChemSusChem. 2019 Jun 21;12(12):2701-2707. doi: 10.1002/cssc.201900678. Epub 2019 May 30.

PMID:
30938473
25.

Proteome-wide solubility and thermal stability profiling reveals distinct regulatory roles for ATP.

Sridharan S, Kurzawa N, Werner T, Günthner I, Helm D, Huber W, Bantscheff M, Savitski MM.

Nat Commun. 2019 Mar 11;10(1):1155. doi: 10.1038/s41467-019-09107-y.

26.

Association between age, uptake of 18F-fluorodeoxyglucose and of 18F-sodium fluoride, as cardiovascular risk factors in the abdominal aorta.

Arani LS, Gharavi MH, Zadeh MZ, Raynor WY, Seraj SM, Constantinescu CM, Gerke O, Werner TJ, Høilund-Carlsen PF, Alavi A.

Hell J Nucl Med. 2019 Jan-Apr;22(1):14-19. doi: 10.1967/s002449910954. Epub 2019 Mar 7.

PMID:
30843005
27.

The role of 18F-FDG PET in the assessment of a benign hematological disorder: polycythemia.

Ayubcha C, Hosoya H, Seraj SM, Zadeh MZ, Werner T, Alavi A.

Hell J Nucl Med. 2019 Jan-Apr;22(1):4-5. doi: 10.1967/s002449910951. Epub 2019 Mar 7.

PMID:
30843002
28.

Dynamics of fluorine-18-fluorodeoxyglucose uptake in the liver and its correlation with hepatic fat content and BMI.

Seraj SM, Al-Zaghal A, Zadeh MZ, Jahangiri P, Pournazari K, Raynor WY, Werner TJ, Høilund-Carlsen PF, Alavi A, Hunt SJ.

Nucl Med Commun. 2019 May;40(5):545-551. doi: 10.1097/MNM.0000000000001000.

PMID:
30807535
29.

The PD-1/PD-L1 Pathway Affects the Expansion and Function of Cytotoxic CD8+ T Cells During an Acute Retroviral Infection.

David P, Megger DA, Kaiser T, Werner T, Liu J, Chen L, Sitek B, Dittmer U, Zelinskyy G.

Front Immunol. 2019 Feb 5;10:54. doi: 10.3389/fimmu.2019.00054. eCollection 2019.

30.

Toward Second-Generation Cardiomyogenic and Anti-cardiofibrotic 1,4-Dihydropyridine-Class TGFβ Inhibitors.

Längle D, Werner TR, Wesseler F, Reckzeh E, Schaumann N, Drowley L, Polla M, Plowright AT, Hirt MN, Eschenhagen T, Schade D.

ChemMedChem. 2019 Apr 17;14(8):810-822. doi: 10.1002/cmdc.201900036. Epub 2019 Feb 28.

PMID:
30768867
31.

Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018).

Berry S, Giraldo N, Nguyen P, Green B, Xu H, Ogurtsova A, Soni A, Succaria F, Wang D, Roberts C, Stein J, Engle E, Pardoll D, Anders R, Cottrell T, Taube JM, Tran B, Voskoboynik M, Kuo J, Bang YL, Chung HC, Ahn MJ, Kim SW, Perera A, Freeman D, Achour I, Faggioni R, Xiao F, Ferte C, Lemech C, Meric-Bernstam F, Werner T, Hodi S, Messersmith W, Lewis N, Talluto C, Dostalek M, Tao A, McWhirter S, Trujillo D, Luke J, Xu C, BoMarelli, Qi J, Qin G, Yu H, Jenkins M, Lo KM, Halle JP, Lan Y, Taylor M, Vogelzang N, Cohn A, Stepan D, Shumaker R, Dutcus C, Guo M, Schmidt E, Rasco D, Brose M, Vogelzang N, Di Simone C, Jain S, Richards D, Encarnacion C, Rasco D, Shumaker R, Dutcus C, Stepan D, Guo M, Schmidt E, Taylor M, Vogelzang N, Encarnacion C, Cohn A, Di Simone C, Rasco D, Richards D, Taylor M, Dutcus C, Stepan D, Shumaker R, Guo M, Schmidt E, Mier J, An J, Yang YY, Lee WH, Yang J, Kim JK, Kim HG, Paek SH, Lee JW, Woo J, Kim JB, Kwon H, Lim W, Paik NS, Kim YK, Moon BI, Janku F, Tan D, Martin-Liberal J, Takahashi S, Geva R, Gucalp A, Chen X, Subramanian K, Mataraza J, Wheler J, Bedard P.

J Immunother Cancer. 2019 Feb 13;7(1):46. doi: 10.1186/s40425-019-0519-y.

32.

Pre-treatment partial-volume-corrected TLG is the best predictor of overall survival in patients with relapsing/refractory non-hodgkin lymphoma following radioimmunotherapy.

Taghvaei R, Zadeh MZ, Sirous R, Shamchi SP, Raynor WY, Seraj SM, Moghbel M, Wang S, Werner TJ, Zhuang H, Alavi A.

Am J Nucl Med Mol Imaging. 2018 Dec 20;8(6):407-414. eCollection 2018.

33.

First-in-human, phase I study of PF-06647263, an anti-EFNA4 calicheamicin antibody-drug conjugate, in patients with advanced solid tumors.

Garrido-Laguna I, Krop I, Burris HA 3rd, Hamilton E, Braiteh F, Weise AM, Abu-Khalaf M, Werner TL, Pirie-Shepherd S, Zopf CJ, Lakshminarayanan M, Holland JS, Baffa R, Hong DS.

Int J Cancer. 2019 Oct 1;145(7):1798-1808. doi: 10.1002/ijc.32154. Epub 2019 Feb 23.

PMID:
30680712
34.

Suboptimal Sensitivity and Specificity of PET and Other Gross Imaging Techniques in Assessing Lymph Node Metastasis.

Alavi A, Carlin SD, Werner TJ, Al-Zaghal A.

Mol Imaging Biol. 2019 Oct;21(5):808-811. doi: 10.1007/s11307-018-01311-4. No abstract available.

PMID:
30675688
35.

Prevalence of clinically significant incidental findings by whole-body fludeoxyglucose F 18 positron emission tomography/computed tomography scanning in moderate-to-severe psoriasis patients participating in clinical trials.

Wan MT, Torigian DA, Alavi A, Alvarez J, Chiesa Fuxench ZC, Noe MH, Papadopoulos M, Shin DB, Takeshita J, Werner TJ, Mehta NN, Gelfand JM.

J Am Acad Dermatol. 2019 Jun;80(6):1630-1639. doi: 10.1016/j.jaad.2019.01.008. Epub 2019 Jan 14.

PMID:
30654078
36.

Intramolecular Base-Free Catalytic Wittig Reaction: Synthesis of Benzoxepinones.

Grandane A, Longwitz L, Roolf C, Spannenberg A, Murua Escobar H, Junghanss C, Suna E, Werner T.

J Org Chem. 2019 Feb 1;84(3):1320-1329. doi: 10.1021/acs.joc.8b02789. Epub 2019 Jan 22.

PMID:
30557512
37.

Physiologic colonic fluorine-18-fluorodeoxyglucose uptake may predict response to immunotherapy in patients with metastatic melanoma.

Boursi B, Werner TJ, Gholami S, Margalit O, Baruch E, Markel G, Eshet Y, Houshmand S, Shacham-Shmueli E, Mitchell TC, Mamtani R, Alavi A, Yang YX.

Melanoma Res. 2019 Jun;29(3):318-321. doi: 10.1097/CMR.0000000000000566.

PMID:
30557217
38.

Incidental 18F-NaF Uptake in Drug-Induced Gynecomastia.

Kothekar E, Raynor WY, Al-Zaghal A, Werner TJ, Alavi A.

Clin Nucl Med. 2019 Apr;44(4):e303-e304. doi: 10.1097/RLU.0000000000002401.

PMID:
30516672
39.

Evolving Role of PET/CT-MRI in Assessing Muscle Disorders.

Kothekar E, Raynor WY, Al-Zaghal A, Jonnakuti VS, Werner TJ, Alavi A.

PET Clin. 2019 Jan;14(1):71-79. doi: 10.1016/j.cpet.2018.08.010. Epub 2018 Oct 24. Review.

PMID:
30420223
40.

Evolving Role of MR Imaging and PET in Assessing Osteoporosis.

Austin AG, Raynor WY, Reilly CC, Zadeh MZ, Werner TJ, Zhuang H, Alavi A, Rajapakse CS.

PET Clin. 2019 Jan;14(1):31-41. doi: 10.1016/j.cpet.2018.08.007. Epub 2018 Oct 24. Review.

PMID:
30420220
41.

Efficacy of 18F-FDG and 18F-NaF PET/CT imaging: A novel semi-quantitative assessment of the effects of age and obesity on hip joint inflammation and bone degeneration.

Yellanki DP, Kothekar E, Al-Zaghal A, Cheng N, Werner TJ, Høilund-Carlsen PF, Alavi A.

Hell J Nucl Med. 2018 Sep-Dec;21(3):181-185. doi: 10.1967/s002449910903. Epub 2018 Nov 10.

42.

Normal patterns of regional brain 18F-FDG uptake in normal aging.

Pourhassan Shamchi S, Khosravi M, Taghvaei R, Zirakchian Zadeh M, Paydary K, Emamzadehfard S, Werner TJ, Høilund-Carlsen PF, Alavi A.

Hell J Nucl Med. 2018 Sep-Dec;21(3):175-180. doi: 10.1967/s002449910902. Epub 2018 Nov 10.

43.

Magnesium Extravaganza: A Critical Compendium of Current Research into Cellular Mg2+ Transporters Other than TRPM6/7.

Kolisek M, Sponder G, Pilchova I, Cibulka M, Tatarkova Z, Werner T, Racay P.

Rev Physiol Biochem Pharmacol. 2019;176:65-105. doi: 10.1007/112_2018_15. Review.

PMID:
30406297
44.

18F-NaF PET/CT in Prostatic Calculi.

Raynor WY, Al-Zaghal A, Werner TJ, Høilund-Carlsen PF, Alavi A.

Clin Nucl Med. 2018 Dec;43(12):e484-e485. doi: 10.1097/RLU.0000000000002317.

PMID:
30325822
45.

Diagnosis and Monitoring of Osteoporosis With 18F-Sodium Fluoride PET: An Unavoidable Path for the Foreseeable Future.

Reilly CC, Raynor WY, Hong AL, Kargilis DC, Lee JS, Alecxih AG, Gupta N, Lim MK, Al-Zaghal A, Werner TJ, Rhodes SS, Alavi A, Rajapakse CS.

Semin Nucl Med. 2018 Nov;48(6):535-540. doi: 10.1053/j.semnuclmed.2018.07.007. Epub 2018 Sep 3. Review.

PMID:
30322479
46.

Applications of PET Imaging in the Evaluation of Musculoskeletal Diseases Among the Geriatric Population.

Al-Zaghal A, Raynor W, Khosravi M, Guermazi A, Werner TJ, Alavi A.

Semin Nucl Med. 2018 Nov;48(6):525-534. doi: 10.1053/j.semnuclmed.2018.07.002. Epub 2018 Aug 6. Review.

PMID:
30322478
47.

The Role of PET in Evaluating Atherosclerosis: A Critical Review.

Moghbel M, Al-Zaghal A, Werner TJ, Constantinescu CM, Høilund-Carlsen PF, Alavi A.

Semin Nucl Med. 2018 Nov;48(6):488-497. doi: 10.1053/j.semnuclmed.2018.07.001. Epub 2018 Aug 30. Review.

PMID:
30322475
48.

Too many women are dying from cervix cancer: Problems and solutions.

Gaffney DK, Hashibe M, Kepka D, Maurer KA, Werner TL.

Gynecol Oncol. 2018 Dec;151(3):547-554. doi: 10.1016/j.ygyno.2018.10.004. Epub 2018 Oct 6. Review.

PMID:
30301561
49.

FDG-PET imaging to detect and characterize underlying causes of fever of unknown origin: an unavoidable path for the foreseeable future.

Al-Zaghal A, Raynor WY, Seraj SM, Werner TJ, Alavi A.

Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):2-7. doi: 10.1007/s00259-018-4164-3. No abstract available.

PMID:
30242428
50.

A prospective study of the feasibility of FDG-PET/CT imaging to quantify radiation-induced lung inflammation in locally advanced non-small cell lung cancer patients receiving proton or photon radiotherapy.

Jahangiri P, Pournazari K, Torigian DA, Werner TJ, Swisher-McClure S, Simone CB 2nd, Alavi A.

Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):206-216. doi: 10.1007/s00259-018-4154-5. Epub 2018 Sep 18.

PMID:
30229527

Supplemental Content

Loading ...
Support Center